US Bancorp’s ImmuCell ICCC Stock Holding History

US Bancorp’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-600	Closed	-$3.2K	–	4055
2023 Q3	$3.2K	Hold	600	–	–	﹤0.01%	3561
2023 Q2	$3K	Hold	600	–	–	﹤0.01%	3601
2023 Q1	$3.07K	Hold	600	–	–	﹤0.01%	3667
2022 Q4	$3.66K	Hold	600	–	–	﹤0.01%	3617
2022 Q3	$4K	Hold	600	–	–	﹤0.01%	3664
2022 Q2	$5K	Hold	600	–	–	﹤0.01%	3586
2022 Q1	$6K	Hold	600	–	–	﹤0.01%	3548
2021 Q4	$5K	Hold	600	–	–	﹤0.01%	3644
2021 Q3	$6K	Hold	600	–	–	﹤0.01%	3585
2021 Q2	$6K	Hold	600	–	–	﹤0.01%	3561
2021 Q1	$6K	Buy	+600	New	+$5.63K	﹤0.01%	3450
2014 Q1	–	Sell	-24	Closed	–	–	3511
2013 Q4	$0	Hold	24	–	–	﹤0.01%	3432
2013 Q3	$0	Hold	24	–	–	﹤0.01%	3298
2013 Q2	$0	Buy	+24	New	+$86	﹤0.01%	3236

Other funds holding ICCC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OMC

Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return

US Bancorp's ICCC Position: Q4 2023 in Review

US Bancorp sold out of ImmuCell (ICCC) in Q4 2023, closing a stake of 600 shares — an estimated $3.2K sold.

US Bancorp first reported a position in ICCC in Q2 2013 and held it in 14 quarters. The position peaked at $6K in Q1 2022. 28 funds tracked by Wall St. Rank hold ICCC as of Q4 2023.

US Bancorp reported no remaining ImmuCell position as of Q4 2023 after selling out during the quarter.
US Bancorp sold 600 ImmuCell shares in Q4 2023, an estimated $3.2K.
US Bancorp first reported a position in ImmuCell in Q2 2013 and held it in 14 quarters.
US Bancorp's ImmuCell position peaked at $6K in Q1 2022.
28 funds tracked by Wall St. Rank held ImmuCell as of Q4 2023.

Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.